CISA’s CSAT Tool Hacked: Systems Offline, Free Webinarsby Lilu Anderson 25.06.2024CISA's CSAT Tool hacked; critical information at risk. Reset passwords, strengthen security, and stay updated through CISA's webinars.
LockBit Claims Massive Breach of Federal Reserve: 33TB Databy Lilu Anderson 25.06.2024"LockBit claims a massive 33TB data breach of the U.S. Federal Reserve, casting doubts as cybersecurity experts question the credibility ...
Dogecoin Army Awaits Twitter’s Adoption as Premium Paymentby John Darbie 25.06.2024"Dogecoin community thrilled by potential DOGE payments on Elon Musk's platform X amid regulatory advancements and optimism despite price dips."
India’s SEBI Targets Stock Derivatives, Influencer Rulesby Mark Eisenberg 25.06.2024"SEBI plans new rules to curb market manipulation, enhance safety in stock derivatives, regulate financial influencers, and simplify delisting procedures."
Bitcoin Price Forecast: Indicators Signal Potential 100% Rallyby John Darbie 25.06.2024Experts say Bitcoin could soon rally by 100%. Key indicators like the Crosby Ratio and RSI suggest now might be ...
Salesforce Exec Tallapragada Sells $228K in Sharesby Mark Eisenberg 25.06.2024Salesforce exec Srinivas Tallapragada sells $228K in shares to cover taxes; Salesforce sees 11% revenue rise, strong market position, and ...
Kaltura Exec Sells $2,278 in Stock Amid Planned Strategyby Mark Eisenberg 25.06.2024Kaltura's Chief Customer Officer Natan Israeli sells company stock under a 10b5-1 plan, retaining a strong shareholding, reflecting confidence in ...
US Car Dealers Reeling from CDK Global Cyberattackby Lilu Anderson 25.06.2024"Cyberattack on CDK Global by ransomware group BlackSuit disrupts operations of major US car dealers like Lithia Motors and AutoNation."
Sonendo Exec Sells Stock; Details on 2024 Revenue Guidanceby Mark Eisenberg 25.06.2024Sonendo’s Chief Talent Officer Roy T. Chen sells $700+ in stocks to cover tax obligations on RSU vesting, maintaining significant ...
CTT Pharma CEO Buys $70 in Stock, Owns 5M+ Sharesby Mark Eisenberg 25.06.2024CTT Pharmaceutical CEO buys $70 in stock, signaling confidence. Despite recent gains, profitability concerns remain. Investors should monitor closely.